Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6474)
All Articles published online
|
Publishing Process of This Article
|
Jul 7, 2018 (publication date) through Apr 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | An Y, Gao S, Zhao WC, Qiu BA, Xia NX, Zhang PJ, Fan ZP. Transforming growth factor-β and peripheral regulatory cells are negatively correlated with the overall survival of hepatocellular carcinoma. World J Gastroenterol 2018; 24(25): 2733-2740 [PMID: 29991878 DOI: 10.3748/wjg.v24.i25.2733] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v24/i25/2733.htm |
| Number | Citing Articles |
| 1 |
Jingwen Luo, Xu-Qiao Chen, Ping Li. The Role of TGF-β and Its Receptors in Gastrointestinal Cancers. Translational Oncology 2019; 12(3): 475 doi: 10.1016/j.tranon.2018.11.010
|
| 2 |
Lisa Derosa, Cléa Melenotte, Franck Griscelli, Bertrand Gachot, Aurélien Marabelle, Guido Kroemer, Laurence Zitvogel. The immuno-oncological challenge of COVID-19. Nature Cancer 2020; 1(10): 946 doi: 10.1038/s43018-020-00122-3
|
| 3 |
Ishwar Navin, Michael T. Lam, Robin Parihar. Design and Implementation of NK Cell-Based Immunotherapy to Overcome the Solid Tumor Microenvironment. Cancers 2020; 12(12): 3871 doi: 10.3390/cancers12123871
|
| 4 |
Yi-Ru Chen, Su-Shan Ouyang, Yan-Ling Chen, Ping Li, Hui-Wen Xu, Sen-Lin Zhu. BRD4/8/9 are prognostic biomarkers and associated with immune infiltrates in hepatocellular carcinoma. Aging 2020; 12(17): 17541 doi: 10.18632/aging.103768
|
| 5 |
Ran Yu, Linbo Jin, Fangfang Li, Manabu Fujimoto, Qiang Wei, Zhenhua Lin, Xiangshan Ren, Quanxin Jin, Honghua Li, Fanping Meng, Guihua Jin. Dihydroartemisinin inhibits melanoma by regulating CTL/Treg anti-tumor immunity and STAT3-mediated apoptosis via IL-10 dependent manner. Journal of Dermatological Science 2020; 99(3): 193 doi: 10.1016/j.jdermsci.2020.08.001
|
| 6 |
Xiu Chen, Liqiu Kou, Xiaolu Xie, Song Su, Jun Li, Yaling Li. Prognostic biomarkers associated with immune checkpoint inhibitors in hepatocellular carcinoma. Immunology 2024; 172(1): 21 doi: 10.1111/imm.13751
|
| 7 |
Federico Costante, Leonardo Stella, Francesco Santopaolo, Antonio Gasbarrini, Maurizio Pompili, Tarik Asselah, Francesca Romana Ponziani. Molecular and Clinical Features of Hepatocellular Carcinoma in Patients with HBV-HDV Infection. Journal of Hepatocellular Carcinoma 2023; : 713 doi: 10.2147/JHC.S384751
|
| 8 |
Li Wu, Fu-Rong Yang, Mu-Lan Xing, Sheng-Feng Lu, Hong-Lin Chen, Qiao-Wei Yang, Yu-Ting Zhang, Yin Lu, Yan Huang. Multi-material basis and multi-mechanisms of the Dahuang Zhechong pill for regulating Treg/Th1 balance in hepatocellular carcinoma. Phytomedicine 2022; 100: 154055 doi: 10.1016/j.phymed.2022.154055
|
| 9 |
Aswathy R Devan, Keechilat Pavithran, Bhagyalakshmi Nair, Maneesha Murali, Lekshmi R Nath. Deciphering the role of transforming growth factor-beta 1 as a diagnostic-prognostic-therapeutic candidate against hepatocellular carcinoma. World Journal of Gastroenterology 2022; 28(36): 5250-5264 doi: 10.3748/wjg.v28.i36.5250
|
| 10 |
Caecilia H C Sukowati, Korri Elvanita El-Khobar, Claudio Tiribelli. Immunotherapy against programmed death-1/programmed death ligand 1 in hepatocellular carcinoma: Importance of molecular variations, cellular heterogeneity, and cancer stem cells. World Journal of Stem Cells 2021; 13(7): 795-824 doi: 10.4252/wjsc.v13.i7.795
|
| 11 |
Christine Ménétrier-Caux, Isabelle Ray-Coquard, Jean-Yves Blay, Christophe Caux. Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?. Journal for ImmunoTherapy of Cancer 2019; 7(1) doi: 10.1186/s40425-019-0549-5
|
| 12 |
David J. Pinato, Nadia Guerra, Petros Fessas, Ravindhi Murphy, Takashi Mineo, Francesco A. Mauri, Sujit K. Mukherjee, Mark Thursz, Ching Ngar Wong, Rohini Sharma, Lorenza Rimassa. Immune-based therapies for hepatocellular carcinoma. Oncogene 2020; 39(18): 3620 doi: 10.1038/s41388-020-1249-9
|
| 13 |
Kendi Nishino Miyamoto, Diego Bonatto. Circulating cells and exosomes in acute myelogenous leukemia and their role in disease progression and survival. Clinical Immunology 2020; 217: 108489 doi: 10.1016/j.clim.2020.108489
|